Literature DB >> 23554186

Prevalence and characteristics of the epidemic multiresistant Escherichia coli ST131 clonal group among extended-spectrum beta-lactamase-producing E. coli isolates in Copenhagen, Denmark.

Bente Olesen1, Dennis S Hansen, Frida Nilsson, Jakob Frimodt-Møller, Rikke Fleron Leihof, Carsten Struve, Flemming Scheutz, Brian Johnston, Karen A Krogfelt, James R Johnson.   

Abstract

We report the characteristics of 115 extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli clinical isolates, from 115 unique Danish patients, over a 1-year study interval (1 October 2008 to 30 September 2009). Forty-four (38%) of the ESBL isolates represented sequence type 131 (ST13)1, from phylogenetic group B2. The remaining 71 isolates were from phylogenetic groups D (27%), A (22%), B1 (10%), and B2 (3%). Serogroup O25 ST131 isolates (n = 42; 95% of ST131) comprised 7 different K antigens, whereas two ST131 isolates were O16:K100:H5. Compared to non-ST131 isolates, ST131 isolates were associated positively with CTX-M-15 and negatively with CTX-M-1 and CTX-M-14. They also were associated positively with 11 virulence genes, including afa and dra (Dr family adhesins), the F10 papA allele (P fimbria variant), fimH (type 1 fimbriae), fyuA (yersiniabactin receptor), iha (adhesin siderophore), iutA (aerobactin receptor), kpsM II (group 2 capsules), malX (pathogenicity island marker), ompT (outer membrane protease), sat (secreted autotransporter toxin), and usp (uropathogenicity-specific protein) and negatively with hra (heat-resistant agglutinin) and iroN (salmochelin receptor). The consensus virulence gene profile (>90% prevalence) of the ST131 isolates included fimH, fyuA, malX, and usp (100% each), ompT and the F10 papA allele (95% each), and kpsM II and iutA (93% each). ST131 isolates were also positively associated with community acquisition, extraintestinal pathogenic E. coli (ExPEC) status, and the O25, K100, and H4 antigens. Thus, among ESBL E. coli isolates in Copenhagen, ST131 was the most prevalent clonal group, was community associated, and exhibited distinctive and comparatively extensive virulence profiles, plus a greater variety of capsular antigens than reported previously.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23554186      PMCID: PMC3716056          DOI: 10.1128/JCM.00346-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  37 in total

1.  Emergence of extended-spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae in Danish hospitals; this is in part explained by spread of two CTX-M-15 clones with multilocus sequence types 15 and 16 in Zealand.

Authors:  Camilla H Lester; Stefan S Olsen; Lotte Jakobsen; Magnus Arpi; Kurt Fuursted; Dennis S Hansen; Ole Heltberg; Anette Holm; Tove Højbjerg; Kjeld Truberg Jensen; Helle Krogh Johansen; Ulrik Stenz Justesen; Michael Kemp; Jenny Dahl Knudsen; Bent Røder; Niels Frimodt-Møller; Anette M Hammerum
Journal:  Int J Antimicrob Agents       Date:  2011-05-25       Impact factor: 5.283

2.  Molecular epidemiology of extraintestinal pathogenic Escherichia coli isolates from a regional cohort of elderly patients highlights the prevalence of ST131 strains with increased antimicrobial resistance in both community and hospital care settings.

Authors:  Gemma Croxall; James Hale; Vivienne Weston; Georgina Manning; Phil Cheetham; Mark Achtman; Alan McNally
Journal:  J Antimicrob Chemother       Date:  2011-08-22       Impact factor: 5.790

3.  Enteroaggregative Escherichia coli O78:H10, the cause of an outbreak of urinary tract infection.

Authors:  Bente Olesen; Flemming Scheutz; Rebecca L Andersen; Megan Menard; Nadia Boisen; Brian Johnston; Dennis S Hansen; Karen A Krogfelt; James P Nataro; James R Johnson
Journal:  J Clin Microbiol       Date:  2012-09-12       Impact factor: 5.948

4.  Multiplex PCR-based reverse line blot assay for simultaneous detection of 22 virulence genes in uropathogenic Escherichia coli.

Authors:  Timothy Kudinha; Fanrong Kong; James R Johnson; Scott D Andrew; Peter Anderson; Gwendolyn L Gilbert
Journal:  Appl Environ Microbiol       Date:  2011-12-09       Impact factor: 4.792

5.  Molecular epidemiological analysis of Escherichia coli sequence type ST131 (O25:H4) and blaCTX-M-15 among extended-spectrum-β-lactamase-producing E. coli from the United States, 2000 to 2009.

Authors:  James R Johnson; Carl Urban; Scott J Weissman; James H Jorgensen; James S Lewis; Glen Hansen; Paul H Edelstein; Ari Robicsek; Timothy Cleary; Javier Adachi; David Paterson; John Quinn; Nancy D Hanson; Brian D Johnston; Connie Clabots; Michael A Kuskowski
Journal:  Antimicrob Agents Chemother       Date:  2012-02-21       Impact factor: 5.191

6.  Detection of quinolone-resistant Escherichia coli isolates belonging to clonal groups O25b:H4-B2-ST131 and O25b:H4-D-ST69 in raw sewage and river water in Barcelona, Spain.

Authors:  Marta Colomer-Lluch; Azucena Mora; Cecilia López; Rosalia Mamani; Ghizlane Dahbi; Juan Marzoa; Alexandra Herrera; Susana Viso; Jesús E Blanco; Miguel Blanco; María Pilar Alonso; Joan Jofre; Maite Muniesa; Jorge Blanco
Journal:  J Antimicrob Chemother       Date:  2012-12-07       Impact factor: 5.790

7.  Emergence and spread of B2-ST131-O25b, B2-ST131-O16 and D-ST405 clonal groups among extended-spectrum-β-lactamase-producing Escherichia coli in Japan.

Authors:  Yasufumi Matsumura; Masaki Yamamoto; Miki Nagao; Gou Hotta; Aki Matsushima; Yutaka Ito; Shunji Takakura; Satoshi Ichiyama
Journal:  J Antimicrob Chemother       Date:  2012-07-26       Impact factor: 5.790

8.  Role of enteroaggregative Escherichia coli virulence factors in uropathogenesis.

Authors:  Erik J Boll; Carsten Struve; Nadia Boisen; Bente Olesen; Steen G Stahlhut; Karen A Krogfelt
Journal:  Infect Immun       Date:  2013-01-28       Impact factor: 3.441

9.  An abbreviated MLVA identifies Escherichia coli ST131 as the major extended-spectrum β-lactamase-producing lineage in the Copenhagen area.

Authors:  J B Nielsen; A Albayati; R L Jørgensen; K H Hansen; B Lundgren; K Schønning
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-11-06       Impact factor: 3.267

10.  Genomic characterization of enteroaggregative Escherichia coli from children in Mali.

Authors:  Nadia Boisen; Flemming Scheutz; David A Rasko; Julia C Redman; Søren Persson; Jakub Simon; Karen L Kotloff; Myron M Levine; Samba Sow; Boubou Tamboura; Aliou Toure; Dramane Malle; Sandra Panchalingam; Karen A Krogfelt; James P Nataro
Journal:  J Infect Dis       Date:  2011-12-19       Impact factor: 5.226

View more
  41 in total

Review 1.  Escherichia coli ST131, an intriguing clonal group.

Authors:  Marie-Hélène Nicolas-Chanoine; Xavier Bertrand; Jean-Yves Madec
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

2.  Emergence of OXA-48-producing Escherichia coli clone ST38 in fowl.

Authors:  Charbel Al Bayssari; Abiola Olumuyiwa Olaitan; Fouad Dabboussi; Monzer Hamze; Jean-Marc Rolain
Journal:  Antimicrob Agents Chemother       Date:  2014-10-27       Impact factor: 5.191

3.  Extensive Household Outbreak of Urinary Tract Infection and Intestinal Colonization due to Extended-Spectrum β-Lactamase-Producing Escherichia coli Sequence Type 131.

Authors:  Theresa Madigan; James R Johnson; Connie Clabots; Brian D Johnston; Stephen B Porter; Billie S Slater; Ritu Banerjee
Journal:  Clin Infect Dis       Date:  2015-03-31       Impact factor: 9.079

4.  Blocking yersiniabactin import attenuates extraintestinal pathogenic Escherichia coli in cystitis and pyelonephritis and represents a novel target to prevent urinary tract infection.

Authors:  Ariel R Brumbaugh; Sara N Smith; Sargurunathan Subashchandrabose; Stephanie D Himpsl; Tracy H Hazen; David A Rasko; Harry L T Mobley
Journal:  Infect Immun       Date:  2015-01-26       Impact factor: 3.441

Review 5.  A new clone sweeps clean: the enigmatic emergence of Escherichia coli sequence type 131.

Authors:  Ritu Banerjee; James R Johnson
Journal:  Antimicrob Agents Chemother       Date:  2014-05-27       Impact factor: 5.191

6.  Epidemic Emergence in the United States of Escherichia coli Sequence Type 131-H30 (ST131-H30), 2000 to 2009.

Authors:  James R Johnson; Stephen Porter; Paul Thuras; Mariana Castanheira
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

7.  Variation in resistance traits, phylogenetic backgrounds, and virulence genotypes among Escherichia coli clinical isolates from adjacent hospital campuses serving distinct patient populations.

Authors:  Sarah M Drawz; Stephen Porter; Michael A Kuskowski; Brian Johnston; Connie Clabots; Susan Kline; Patricia Ferrieri; James R Johnson
Journal:  Antimicrob Agents Chemother       Date:  2015-06-22       Impact factor: 5.191

Review 8.  Pathogenesis of human diffusely adhering Escherichia coli expressing Afa/Dr adhesins (Afa/Dr DAEC): current insights and future challenges.

Authors:  Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

9.  Diagnostic potential of monoclonal antibodies specific to the unique O-antigen of multidrug-resistant epidemic Escherichia coli clone ST131-O25b:H4.

Authors:  Valéria Szijártó; Jolanta Lukasiewicz; Tomasz K Gozdziewicz; Zoltán Magyarics; Eszter Nagy; Gábor Nagy
Journal:  Clin Vaccine Immunol       Date:  2014-04-30

10.  First Report of Prevalence of CTX-M-15-Producing Escherichia coli O25b/ST131 from Iran.

Authors:  Mohammad Hasan Namaei; Masoud Yousefi; Masoud Ziaee; Alireza Salehabadi; Malaknaz Ghannadkafi; Elham Amini; Parvin Askari
Journal:  Microb Drug Resist       Date:  2017-02-16       Impact factor: 3.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.